FJ
Frank Condella Jr
Director

Frank Condella Jr insider trades: Juniper Pharmaceuticals (JNP) stock buys and sales

Director, Juniper Pharmaceuticals Last trade Nov 18, 2015 23 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2005
3
Companies
last trade 2015

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Frank reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 18, 2015JNP↑ Buy$58K
May 8, 2015JNP↑ Buy$74K
Aug 13, 2014CBRX↑ Buy$60K
May 5, 2014CBRX↑ Buy$67K
Nov 26, 2013CBRX↑ Buy$32K
May 15, 2013CBRX↑ Buy$51K
Mar 15, 2010CBRX↑ Buy$112K
Jun 6, 2005IVX↓ Sell$1.1M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Frank Condella Jr's insider trades

Frank Condella Jr is a director at Juniper Pharmaceuticals (JNP). Since Jun 6, 2005, Frank has reported 7 open-market purchases worth $453K and 1 sale worth $1.1M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (13 filings), option exercises (2 filings), shares withheld for taxes (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every JNP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.